Ascendis Pharma Endocrinology, INC.
Biopharmaceutical therapies developed with TransCon technology
Visit website ContactClaim & upgrade this listingContact details are protected Something wrong? Suggest a correction
Ascendis Pharma develops biopharmaceutical therapies using its TransCon technology platform for patients with endocrine rare diseases and cancer. Its programs include clinical-stage product candidates, alongside collaborations with partners to develop TransCon-based treatments for additional therapeutic areas and markets.
At a Glance
Ascendis Pharma Endocrinology, INC. is an American manufacturer based in Princeton, NJ.
- Where
- Princeton, NJ
